Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
2 clinical trials · Condition
◉ Watch Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer (NCT03575234) | Emory University | 2020-07-01 |
| ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment (NCT02917629) | National Cancer Institute (NCI) | 2018-05-31 |
Track Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.